PLRZ earnings: real EPS beat/miss history, P/E -4.12. Updated 2026-07-23.
Polyrizon (PLRZ) Research Hub
Polyrizon (PLRZ) trades on NASDAQ, IL in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 11.03 USD (+2.60%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.12, market cap 0.02B. This hub links to the full technical, earnings and options research available for PLRZ.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, IL |
| Last close | 11.03 USD (+2.60%) |
| 52-week range | 9.51 USD – 15.91 USD |
| Trend regime | Range |
| 14-day RSI | 47.5 (Neutral) |
| Trailing P/E | -4.12 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
Available research for PLRZ
Covered Call on PLRZ: how it works, illustrative setup around the real 11.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PLRZ: how it works, illustrative setup around the real 11.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PLRZ: how it works, illustrative setup around the real 11.03 USD price, max profit/loss, breakeven and when to use it. Educational.
PLRZ technical analysis: range, last 11.03 USD, RSI 47.5, 52w range 9.51 USD–15.91 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is PLRZ in?
Polyrizon (PLRZ) is classified under Healthcare (Biotechnology), listed on NASDAQ, IL.
Is PLRZ in an uptrend or downtrend?
As of 2026-09-11, PLRZ is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PLRZ's trailing P/E ratio?
PLRZ's trailing P/E is -4.12, with a market cap of 0.02B. See the earnings research page for full valuation detail.